InnoCan Pharma Corporation (CSE:INNO)

Canada · Delayed Price · Currency is CAD

3.600

+0.200 (5.88%)

Jun 10, 2026, 1:44 PM EST

Revenue by Segment

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018
Online Sales	26.60M	29.40M	13.55M	2.42M	-
Online Sales Growth	-9.53%	117.00%	458.91%	-	-
Other Operations	15.00K	38.00K	109.00K	135.00K	-
Other Operations Growth	-60.53%	-65.14%	-19.26%	-	-
Pharmaceuticals	-	-	-	-	196.00K
Pharmaceuticals Growth	-	-	-	-	2350.00%
Total	26.61M	29.44M	13.66M	2.56M	196.00K
Total Growth	-9.60%	115.55%	433.69%	1205.61%	2350.00%

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018
United States	26.60M	29.40M	13.55M	2.42M	34.00K
United States Growth	-9.53%	117.00%	460.53%	7008.82%	-
Rest of The World	15.00K	38.00K	109.00K	59.00K	41.00K
Rest of The World Growth	-60.53%	-65.14%	84.75%	43.90%	412.50%
United Kingdom	-	-	-	83.00K	-
France	-	-	-	-	61.00K
Poland	-	-	-	-	60.00K
Total	26.61M	29.44M	13.66M	2.56M	196.00K
Total Growth	-9.60%	115.55%	433.69%	1205.61%	2350.00%

Source: S&P Global Market Intelligence.